ATE91412T1 - Kalziumpantothenatzusammensetzung. - Google Patents

Kalziumpantothenatzusammensetzung.

Info

Publication number
ATE91412T1
ATE91412T1 AT90304169T AT90304169T ATE91412T1 AT E91412 T1 ATE91412 T1 AT E91412T1 AT 90304169 T AT90304169 T AT 90304169T AT 90304169 T AT90304169 T AT 90304169T AT E91412 T1 ATE91412 T1 AT E91412T1
Authority
AT
Austria
Prior art keywords
calcium pantothenate
ingredients
composite
stable
calcium
Prior art date
Application number
AT90304169T
Other languages
English (en)
Inventor
Junzou Yamashita
Yasuo Ono
Kunihiko Sumimura
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE91412T1 publication Critical patent/ATE91412T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
AT90304169T 1989-04-19 1990-04-19 Kalziumpantothenatzusammensetzung. ATE91412T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9963789 1989-04-19
JP17944089 1989-07-11

Publications (1)

Publication Number Publication Date
ATE91412T1 true ATE91412T1 (de) 1993-07-15

Family

ID=26440747

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90304169T ATE91412T1 (de) 1989-04-19 1990-04-19 Kalziumpantothenatzusammensetzung.

Country Status (8)

Country Link
US (1) US5089276A (de)
EP (1) EP0394022B1 (de)
JP (1) JP2891744B2 (de)
AT (1) ATE91412T1 (de)
DE (1) DE69002186T2 (de)
DK (1) DK0394022T3 (de)
ES (1) ES2058793T3 (de)
HU (1) HU208626B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2252905B (en) * 1991-02-11 1995-05-10 Leung Lit Hung An agent for correcting a deficiency of androgenic steroids
AU1798300A (en) 1998-12-25 2000-07-31 Fuji Chemical Industries, Ltd. Method for producing calcium pantothenate
US8232081B2 (en) * 1999-09-21 2012-07-31 Basf Se Methods and microorganisms for production of panto-compounds
US6509496B1 (en) 2000-10-19 2003-01-21 Nutrapure, Inc. Process for making mineral, food or pharmaceutical grade salt products
US6887492B2 (en) 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
JP4841130B2 (ja) * 2004-10-12 2011-12-21 武田薬品工業株式会社 安定化されたビタミン製剤
JP4615470B2 (ja) 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
SI2164975T1 (sl) 2007-07-06 2012-06-29 Basf Se Postopek za proizvajanje koncentriranega vodnega glukoznega pripravka iz koruze
WO2009016025A1 (en) * 2007-07-31 2009-02-05 Dsm Ip Assets B.V. Process for the synthesis of na- beta-alaninate and calcium pantothenate
JP5524130B2 (ja) * 2011-05-19 2014-06-18 武田薬品工業株式会社 安定化されたビタミン製剤
JPWO2019013234A1 (ja) 2017-07-11 2020-07-02 武田コンシューマーヘルスケア株式会社 ビタミンb1類を配合する固形製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864701A (en) * 1954-04-30 1958-12-16 Merck & Co Inc Stabilized pantothenic acid compositions
US2992273A (en) * 1958-03-12 1961-07-11 Nopco Chem Co Preparation of dense calcium pantothenate
US3092548A (en) * 1960-10-27 1963-06-04 Warren Teed Products Company Method of treating peptic ulcers with pantothenic acid
US3247064A (en) * 1962-03-30 1966-04-19 Shionogi & Co Multivitamin tablet stabilized with porous silica
RO68298A2 (ro) * 1975-08-05 1980-04-15 Intreprinderea De Medicamente,Ro Compozitie pe baza de saruri organice de calciu si magneziu usor asimilabile si cu o solubilitate crescuta,si procedeu de preparare a acesteia

Also Published As

Publication number Publication date
DE69002186T2 (de) 1994-01-27
HU902470D0 (en) 1990-08-28
JP2891744B2 (ja) 1999-05-17
DK0394022T3 (da) 1993-08-23
HUT54040A (en) 1991-01-28
EP0394022B1 (de) 1993-07-14
DE69002186D1 (de) 1993-08-19
ES2058793T3 (es) 1994-11-01
JPH03123729A (ja) 1991-05-27
HU208626B (en) 1993-12-28
US5089276A (en) 1992-02-18
EP0394022A1 (de) 1990-10-24

Similar Documents

Publication Publication Date Title
DE69002186D1 (de) Kalziumpantothenatzusammensetzung.
JPS53138446A (en) Resin composition
JPS53127819A (en) Stabilization of l-asocorbic acid and its salt
JPS5664658A (en) Karl fisher reagent
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
JPS57140723A (en) Preventing composition for hyperlipemia due to neutral fat
ATE165712T1 (de) Stabilisierte nahrungsmittelzusammensetzung
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
JPS5726587A (en) Stabilization of ascorbic acid oxidase
JPS55157643A (en) Polymer composition
JPS5379860A (en) Preparation of 1-acyl-3-indolinone derivs.
JPS5328693A (en) Polyester polyestier rlow molded articles or other preliminary molded article
JPS5273996A (en) Preparation of polyesters
JPS5650958A (en) Resin composition
JPS5363457A (en) Jelly compositions
JPS5568286A (en) Culture medium of sawdust for fungus mycellia
JPS6430563A (en) Concentrated and dried juice of plum or watermelon and preparation thereof
JPS5283413A (en) Preparation of 3,3-dimethyl-4-pentenoic acid or its esters
KR920700658A (ko) 칼륨 보충을 위한 약학 조성물
JPS5432487A (en) Preparation of 1-carbamoyluracils
JPS5278707A (en) Preparation of low aluminum ferro-silicon
JPS5515452A (en) Aromatic composition
JPS52100553A (en) Preparation of resin compositions
JPS53111345A (en) Resin composition
JPS55108258A (en) Preparation of feed for fish

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee